← Leaderboards
Vasiliki Poulaki
Va Boston Health Care System
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2013–16$1$1$1$0$0
'13
'14
'15
'16
Funding mix
By agency
VA$0 · 1
By mechanism
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Va Boston Health Care System
Same institution · by research overlap
- Aldebaran M Hofer$706,241
Others in their field
Top investigators on “Effective Therapy”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lawrence Corey · Fred Hutchinson Cancer Center$467,028,615
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$263,149,639
- Constance Ann Benson · University Of California, San Diego$228,304,380
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
Effective TherapyAdultAggressive TherapyBaseBostonAnticancer ActivityAntineoplastic AgentsCancer Cell GrowthCancer TherapyCaringCause Of DeathCell LineCellular BiologyBraf GeneBreastCollaborationsCollegeColon CarcinomaComputer SimulationCountryCutaneous MelanomaDesignDiagnosisForging
Grant awards (4)
TARGETING G(alpha)q AND SRC-3 SIGNALING AS A NOVEL THERAPEUTIC APPROACH IN MELANO$0
I01 · FY2016 · VA · contact PI
TARGETING G(alpha)q AND SRC-3 SIGNALING AS A NOVEL THERAPEUTIC APPROACH IN MELANO$0
I01 · FY2015 · VA · contact PI
TARGETING G(alpha)q AND SRC-3 SIGNALING AS A NOVEL THERAPEUTIC APPROACH IN MELANO$0
I01 · FY2014 · VA · contact PI
TARGETING G(alpha)q AND SRC-3 SIGNALING AS A NOVEL THERAPEUTIC APPROACH IN MELANO$0
I01 · FY2013 · VA · contact PI